Literature DB >> 10795113

Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics.

M C Rangel1, V G Coronado, G L Euler, R A Strikas.   

Abstract

Pediatric patients on dialysis should receive all the vaccines currently recommended by the ACIP and the AAP for healthy children, except the oral polio vaccine (34, 35). Adult patients should receive the hepatitis B vaccine series, pneumococcal vaccine, yearly influenza vaccinations, tetanus-diphtheria toxoids, and varicella vaccine, if they are susceptible (33, 48, 69). Vaccines are well tolerated by these patients (33), but higher doses and/or additional boosters may be required periodically to adequately protect dialysis patients from vaccine-preventable diseases (33, 36, 37, 82, 83). Following vaccination, antibody concentrations for hepatitis B vaccine should be measured annually and booster doses administered when antibody concentrations fall below protective levels (33, 38). Although both children and adults on dialysis may show an impaired and/or delayed immunologic response to certain antigens, particularly hepatitis B virus and S. pneumoniae, appropriate immunizations can significantly reduce the risk of serious complications from vaccine-preventable diseases (11, 84). Because the protection these vaccines provide may be incomplete or transient, infection control strategies at hospitals and other health care facilities should be implemented simultaneously. Health care providers are encouraged to assess each patients need for vaccinations individually and formulate immunization strategies early in the course of progressive renal disease, ideally before the patient requires dialysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10795113     DOI: 10.1046/j.1525-139x.2000.00029.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  23 in total

1.  Meta-analysis: the impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease.

Authors:  Fabrizio Fabrizi; Vivek Dixit; Paul Martin; Michel Jadoul; Piergiorgio Messa
Journal:  Dig Dis Sci       Date:  2011-12-06       Impact factor: 3.199

2.  Sex bias in response to hepatitis B vaccination in end-stage renal disease patients: Meta-analysis.

Authors:  Hossein Khedmat; Aghdas Aghaei; Mohammad Ebrahim Ghamar-Chehreh; Shahram Agah
Journal:  World J Nephrol       Date:  2016-01-06

Review 3.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

4.  No effect of serum parathyroid hormone level on antigen presenting cell-dependent T-cell reactivity in hemodialysis patients.

Authors:  Theodoros Eleftheriadis; Vassilis Liakopoulos; Georgia Antoniadi; Antigoni Poultsidi; Alexandros Kortsaris; Ioannis Stefanidis; Vassilis Vargemezis
Journal:  Int Urol Nephrol       Date:  2007-02-16       Impact factor: 2.370

Review 5.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

6.  A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix B®, among vaccine naïve and vaccine non-responder dialysis patients.

Authors:  E Elhanan; M Boaz; I Schwartz; D Schwartz; G Chernin; H Soetendorp; A Gal Oz; A Agbaria; T Weinstein
Journal:  Clin Exp Nephrol       Date:  2017-04-29       Impact factor: 2.801

7.  Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients.

Authors:  Jungmin Son; Soo Bong Lee; Dong Won Lee; Il Young Kim; Su Jin Lee; Sun Min Lee; Sang Heon Song; Eun Young Seong; Ihm Soo Kwak
Journal:  Clin Exp Nephrol       Date:  2012-09-19       Impact factor: 2.801

8.  Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study.

Authors:  Jason M Misurac; Rene G VanDeVoorde; Mahmoud Kallash; Franca M Iorember; Kera E Luckritz; Michelle N Rheault; Jennifer G Jetton; Martin A Turman; Gaurav Kapur; Katherine E Twombley; Shireen Hashmat; Donald J Weaver; Jeffrey D Leiser; Corina Nailescu
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-07       Impact factor: 8.237

Review 9.  Unsolved problems and future perspectives of hepatitis B virus vaccination.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

Review 10.  Evolution of hepatitis B management in kidney transplantation.

Authors:  Desmond Y H Yap; Tak Mao Chan
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.